Загрузка...
Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer
BACKGROUND: Metastatic breast cancer (MBC) rest an incurably disease associated with bad prognosis and a median overall survival of 23–31 months. There are several treatment options including chemotherapy and sometimes endocrine therapy. Currently, there is no standard treatment for patients with MB...
Сохранить в:
| Опубликовано в: : | BMC Cancer |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6102904/ https://ncbi.nlm.nih.gov/pubmed/30126360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4725-7 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|